{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ian+Murray&AnsweringBody.=Department+for+Science%2C+Innovation+and+Technology&answer.dateOfAnswer=2024-03-21", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Ian+Murray&AnsweringBody.=Department+for+Science%2C+Innovation+and+Technology&answer.dateOfAnswer=2024-03-21", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ian+Murray&AnsweringBody.=Department+for+Science%2C+Innovation+and+Technology&answer.dateOfAnswer=2024-03-21&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ian+Murray&_page=0&AnsweringBody.=Department+for+Science%2C+Innovation+and+Technology&answer.dateOfAnswer=2024-03-21", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ian+Murray&AnsweringBody.=Department+for+Science%2C+Innovation+and+Technology&answer.dateOfAnswer=2024-03-21", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ian+Murray&AnsweringBody.=Department+for+Science%2C+Innovation+and+Technology&answer.dateOfAnswer=2024-03-21", "items" : [{"_about" : "http://data.parliament.uk/resources/1695759", "AnsweringBody" : [{"_value" : "Department for Science, Innovation and Technology"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1695759/answer", "answerText" : {"_value" : "

The government is investing significantly to support manufacturing and delivery of cell and gene therapies.<\/p>

Since 2021, government has launched three UK-wide capital grant schemes \u2013 up to £118 million of funds \u2013 to incentivise manufacturing investments, including in advanced therapies. Last year, government announced a further £520 million to increase investment in Life Sciences manufacturing.<\/p>

<\/p>

The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult which also coordinates the Advanced Therapy Treatment Centre network.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4874", "label" : {"_value" : "Biography information for Andrew Griffith"} } , "answeringMemberConstituency" : {"_value" : "Arundel and South Downs"} , "answeringMemberPrinted" : {"_value" : "Andrew Griffith"} , "dateOfAnswer" : {"_value" : "2024-03-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-03-21T09:26:38.747Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "216"} , "answeringDeptShortName" : {"_value" : "Science, Innovation and Technology"} , "answeringDeptSortName" : {"_value" : "Science, Innovation and Technology"} , "date" : {"_value" : "2024-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Advanced Therapy Medicinal Products: Scotland"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to increase Scotland\u2019s (a) manufacturing capacity for and (b) delivery of cell and gene therapies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3966", "label" : {"_value" : "Biography information for Ian Murray"} } , "tablingMemberConstituency" : {"_value" : "Edinburgh South"} , "tablingMemberPrinted" : [{"_value" : "Ian Murray"} ], "uin" : "18417"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }